Disease Info Card

Vascular Anomaly

Information about Vascular Anomaly: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Vascular Anomaly

Most recent studies have shown that Vascular Anomaly shares some biological mechanisms with aneurysm, arteriovenous-fistula, arteriovenous-malformation, brain-neoplasms, cerebral-hemorrhage, congenital-abnormality, congenital-vascular-anomaly, gastrointestinal-hemorrhage, hemangioma, hemangioma-cavernous, hematoma, hemorrhage, hypertensive-disease, intracranial-aneurysm, intracranial-arteriovenous-malformation, neoplasms, pain, pathologic-fistula, telangiectasis, thrombosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Vascular Anomaly, and have been seen in publications frequently: Aging, Angiogenesis, Blood Coagulation, Brain Development, Cell Death, Cell Proliferation, Coagulation, Endothelial Cell Proliferation, Hemostasis, Localization, Lymphangiogenesis, Ossification, Pathogenesis, Pigmentation, Platelet Aggregation, Reflex, Segmentation, Transport, Transposition, Vasculogenesis

Quite a number of genes have been found to play important roles in Vascular Anomaly, such as ACAT1, ACVRL1, CCM2, CSF2, CTLA4, ENG, FGF2, GNAI1, HBA1, HLA-DQA1, KRIT1, LAMC2, NLRP5, NOD2, PDCD10, PECAM1, SLC25A5, SLC2A1, VEGFA, VWF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.